Report from the fourth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative)

British Journal of Dermatology

Volumn 175, Issue 1, 2016, Pages 69-79

  Chalmers, J R ^a   Simpson, E ^b   Apfelbacher, C J ^c   Thomas, K S ^a   von Kobyletzki, L ^d,e   Schmitt, J ^f   Singh, J A ^g,h   Svensson, A ⁱ   Williams, H C ^a   Abuabara, K ^j   Aoki, V ^k   Ardeleanu, M ^l   Awici Rasmussen, M ^m   Barbarot, S ⁿ   Berents, T L ^o,p   Block, J ^q   Bragg, A ^r   Burton, T ^s   Bjerring Clemmensen, K K ^t   Creswell Melville, A ^u   Dinesen, M ^v   Drucker, A ^w   Eckert, L ^x   Flohr, C ^y   Garg, M ^z   Gerbens, L A A ^aa   Graff, A L B ^ab   Hanifin, J ^b   Heinl, D ^c   Humphreys, R ^ab   Ishii, H A ^ac   Kataoka, Y ^ad   Leshem, Y A ^b   Marquort, B ^s   Massuel, M A ^x   Merhand, S ^ae   Mizutani, H ^af   Murota, H ^ag   Murrell, D F ^ah,ai   Nakahara, T ^aj   Nasr, I ^s   Nograles, K ^ak   Ohya, Y ^al   Osterloh, I ^am   Pander, J ^an   Prinsen, C ^ao   Purkins, L ^ap   Ridd, M ^aq   Sach, T ^ar   Schuttelaar, M L A ^as   Shindo, S ^ag   Smirnova, J ^e   Sulzer, A ^x   Synnove Gjerde E ^m   Takaoka, R ^k   Vestby Talmo, H ^x   Tauber, M ^at   Torchet, F ^af   Volke, A ^au   Wahlgren, C F ^av,aw   Weidinger, S ^ax   Weisshaar, E ^ay   Wollenberg, A ^az   Yamaga, K ^ag   Zhao, C Y ^ah,ai   Spuls, P I ^aa   more..

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c UNIVERSITY OF REGENSBURG   (Germany)

^d LUND UNIVERSITY   (Sweden)

^e KARLSTAD UNIVERSITY   (Sweden)

^f DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^g BIRMINGHAM VA MEDICAL CENTER   (United States)

^h University of Alabama at Birmingham   (United States)

ⁱ LUND UNIVERSITY HOSPITAL   (Sweden)

^j UNIVERSITY OF CALIFORNIA   (United States)

^k UNIVERSITY OF SÃO PAULO   (Brazil)

^l REGENERON PHARMACEUTICALS INC   (United States)

^m Psoriasis and Eczema Association of Norway   (Norway)

ⁿ NANTES UNIVERSITY HOSPITAL   (France)

^o UNIVERSITY OF OSLO   (Norway)

^p OSLO UNIVERSITY HOSPITAL   (Norway)

^q National Eczema Association for Science and Education   (United States)

^r Chugai Pharma   (United Kingdom)

^s Chugai Pharma Europe Ltd ^*

^t UNIVERSITY OF COPENHAGEN   (Denmark)

^u Société Canadienne de l'Eczéma   (Canada)

^v LEO PHARMA A S   (Denmark)

^w UNIVERSITY HEALTH NETWORK   (Canada)

^x SANOFI   (France)

^y GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^z Leo Pharma   (Denmark)

^aa UNIVERSITY OF AMSTERDAM   (Netherlands)

^ab NATIONAL ECZEMA SOCIETY   (United Kingdom)

^ac Brazilian Atopic Dermatitis Association (AADA)   (Brazil)

^ad OSAKA PREFECTURAL MEDICAL CENTER FOR RESPIRATORY AND ALLERGIC DISEASES   (Japan)

^ae Association Française de l Eczéma   (France)

^af MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^ag OSAKA UNIVERSITY   (Japan)

^ah ST GEORGE HOSPITAL   (Australia)

^ai UNIVERSITY OF NEW SOUTH WALES   (Australia)

^aj KYUSHU UNIVERSITY   (Japan)

^ak CELGENE CORPORATION   (United States)

^al NATIONAL CENTER FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^am OsterMed   (United Kingdom)

^an Celgene BV   (Netherlands)

^ao VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^ap Ziarco Pharma Ltd   (United Kingdom)

^aq UNIVERSITY OF BRISTOL   (United Kingdom)

^ar UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^as UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^at UNIVERSITÉ DE TOULOUSE   (France)

^au UNIVERSITY OF TARTU   (Estonia)

^av KAROLINSKA INSTITUTE   (Sweden)

^aw KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^ax UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^ay UNIVERSITY OF HEIDELBERG   (Germany)

^az UNIVERSITY OF MUNICH   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ATOPIC DERMATITIS; ATOPIC DERMATITIS QUICKSCORE; DERMATITIS; DERMATOLOGY LIFE QUALITY INDEX; DRY SKIN; HUMAN; ITCH SEVERITY SCALE; MEASUREMENT ERROR; MORBIDITY; NOTTINGHAM ECZEMA SEVERITY SCORE; OUTCOME ASSESSMENT; PAIN; PATIENT ORIENTED ECZEMA MEASURE; PATIENT ORIENTED SCORING ATOPIC DERMATITIS INDEX; PRIORITY JOURNAL; PRURITUS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RELIABILITY; SELF ADMINISTERED ECZEMA AREA AND SEVERITY INDEX; SKIN DISEASE ASSESSMENT; SKIN IRRITATION; SKIN REDNESS; SLEEP DEPRIVATION; SYSTEMATIC REVIEW (TOPIC);

EID: 84982965481     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.14773     Document Type: Article

References (19)

1. HOME IV Meeting, Malmö, Sweden,, 2015. Available at http://www.nottingham.ac.uk/homeforeczema/meetings-and-events/home-iv-meeting-2015.aspx (last accessed 21 June 2016).
2. Schmitt J, Spuls P, Boers M et al. Towards global consensus on outcome measures for atopic eczema research: results of the HOME II meeting. Allergy 2012; 67:1111–17.
3. Schmitt J, Spuls PI, Thomas KS et al. The Harmonising Outcome Measures for Eczema (HOME) statement to assess clinical signs of atopic eczema in trials. J Allergy Clin Immunol 2014; 134:800–7.
4. Schmitt J, Williams H. Harmonising Outcome Measures for Eczema (HOME), Report from the First International Consensus Meeting (HOME 1), 24 July 2010, Munich, Germany. Br J Dermatol 2010; 163:1166–8.
5. Schmitt J, Apfelbacher C, Spuls PI et al. The Harmonizing Outcome Measures for Eczema (HOME) roadmap: a methodological framework to develop core sets of outcome measurements in dermatology. J Invest Dermatol 2015; 135:24–30.
6. Mokkink LB, Terwee CB, Patrick DL et al. The COSMIN study reached international consensus on taxonomy, terminology, and definitions of measurement properties for health-related patient-reported outcomes. J Clin Epidemiol 2010; 63:737–45.
7. Mokkink LB, Terwee CB, Patrick DL et al. The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments: an international Delphi study. Qual Life Res 2010; 19:539–49.
8. Terwee CB, Bot SD, de Boer MR et al. Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol 2007; 60:34–42.
9. Heinl D, Prinsen CA, Deckert S et al. Measurement properties of adult quality-of-life measurement instruments for eczema: a systematic review. Allergy 2016; 71:358–70.
10. Schmitt J, Langan S, Stamm T, Williams HC; Harmonizing Outcome Measurements in Eczema (HOME) Delphi panel. Core outcome domains for controlled trials and clinical recordkeeping in eczema: international multiperspective Delphi consensus process. J Invest Dermatol 2011; 131:623–30.
11. Schmitt J, Langan S, Deckert S et al. Assessment of clinical signs of atopic dermatitis: a systematic review and recommendation. J Allergy Clin Immunol 2013; 132:1337–47.
12. Schmitt J, Langan S, Williams HC; European Dermato-Epidemiology Network. What are the best outcome measurements for atopic eczema? A systematic review. J Allergy Clin Immunol 2007; 120:1389–98.
13. Schram ME, Spuls PI, Leeflang MM et al. EASI, (objective) SCORAD and POEM for atopic eczema: responsiveness and minimal clinically important difference. Allergy 2012; 67:99–106.
14. Gerbens LAA, Chalmers JR, Rogers NK et al. Reporting of symptoms in randomised controlled trials of atopic eczema treatments: a systematic review. Br J Dermatol 2016; doi: 10.1111/bjd.14588. [Epub ahead of print].
15. Gerbens LAA, Prinsen AC, Chalmers JR et al. Evaluation of the measurement properties of symptom measurement instruments for atopic eczema: a systematic review. Allergy 2016; doi: 10.1111/all.12959. [Epub ahead of print].
16. Heinl D, Chalmers J, Nankervis H, Apfelbacher CJ. Eczema trials: quality of life instruments used and their relation to patient-reported outcomes. A systematic review. Acta Derm Venereol 2016; 96:596–601.
17. Barbarot S, Rogers NK, Abuabara K et al. Strategies for measuring long-term control in atopic dermatitis trials: a systematic review. J Am Acad Dermatol 2016. (in press).
18. von Kobyletzki LB, Thomas KS, Schmitt J et al. What Factors are Important to Patients when Assessing Treatment Response: An International Cross-sectional Survey. Acta Derm Venereol 2016. doi: 10.2340/00015555-2480. [Epub ahead of print].
19. Charman CR, Venn AJ, Williams HC. The patient-oriented eczema measure: development and initial validation of a new tool for measuring atopic eczema severity from the patients’ perspective. Arch Dermatol 2004; 140:1513–19.